Meribank Biotech Co Stock

Meribank Biotech Co Equity 2024

Meribank Biotech Co Equity

471.2 M TWD

Ticker

4724.TWO

ISIN

TW0004724000

In 2024, Meribank Biotech Co's equity was 471.2 M TWD, a -19.6% increase from the 586.05 M TWD equity in the previous year.

Meribank Biotech Co Aktienanalyse

What does Meribank Biotech Co do?

Meribank Biotech Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing Meribank Biotech Co's Equity

Meribank Biotech Co's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Meribank Biotech Co's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Meribank Biotech Co's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Meribank Biotech Co's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Meribank Biotech Co’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Meribank Biotech Co stock

What is the equity of Meribank Biotech Co this year?

Meribank Biotech Co has equity of 471.2 M TWD this year.

What was the equity of Meribank Biotech Co compared to the previous year?

The equity of Meribank Biotech Co has increased/decreased by -19.6% decreased compared to the previous year.

What impact does a high equity have on investors of Meribank Biotech Co?

A high equity is advantageous for investors of Meribank Biotech Co as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of Meribank Biotech Co?

A low equity can be a risk for investors of Meribank Biotech Co, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of Meribank Biotech Co affect the company?

An increase in equity of Meribank Biotech Co can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of Meribank Biotech Co affect the company?

A reduction in equity of Meribank Biotech Co can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of Meribank Biotech Co?

Some factors that can affect the equity of Meribank Biotech Co include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of Meribank Biotech Co so important for investors?

The equity of Meribank Biotech Co is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can Meribank Biotech Co take to change the equity?

To change equity, Meribank Biotech Co can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does Meribank Biotech Co pay?

Over the past 12 months, Meribank Biotech Co paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Meribank Biotech Co is expected to pay a dividend of 0 TWD.

What is the dividend yield of Meribank Biotech Co?

The current dividend yield of Meribank Biotech Co is .

When does Meribank Biotech Co pay dividends?

Meribank Biotech Co pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Meribank Biotech Co?

Meribank Biotech Co paid dividends every year for the past 0 years.

What is the dividend of Meribank Biotech Co?

For the upcoming 12 months, dividends amounting to 0 TWD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Meribank Biotech Co located?

Meribank Biotech Co is assigned to the '-' sector.

Wann musste ich die Aktien von Meribank Biotech Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Meribank Biotech Co from 11/12/2024 amounting to 0 TWD, you needed to have the stock in your portfolio before the ex-date on 11/12/2024.

When did Meribank Biotech Co pay the last dividend?

The last dividend was paid out on 11/12/2024.

What was the dividend of Meribank Biotech Co in the year 2023?

In the year 2023, Meribank Biotech Co distributed 0 TWD as dividends.

In which currency does Meribank Biotech Co pay out the dividend?

The dividends of Meribank Biotech Co are distributed in TWD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Meribank Biotech Co

Our stock analysis for Meribank Biotech Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Meribank Biotech Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.